NF-κB translocation and endothelial cell activation is potentiated by macrophage-released signals co-secreted with TNF-α and IL-1β

Inflammation Research

Volumn 53, Issue 10, 2004, Pages 567-575

  Lopez Bojorquez L N ^a   Arechavaleta Velasco, F ^b   Vadillo Ortega, F ^c   Montes Sanchez D ^a   Ventura Gallegos, J L ^a   Zentella Dehesa, A ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Conditioned Media; HUVEC; Inflammation; Innate immunity; LPS activated macrophage inflammatory products

Indexed keywords

I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROTEIN SUBUNIT; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; I KAPPA B; INTERLEUKIN 1; ISOPROTEIN;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL NUCLEUS; CELL STRAIN U937; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; CYTOPLASM; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; METABOLISM; PROTEIN TRANSPORT; TIME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL NUCLEUS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES; NF-KAPPA B; PROTEIN ISOFORMS; PROTEIN TRANSPORT; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; UMBILICAL VEINS;

EID: 12344293662     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1297-6     Document Type: Article

References (36)

1. Bochud PY, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. Bmj 2003; 326: 262-6.
2. Zentella A, Manogue K, Cerami A. The role of cachectin/TNF and other cytokines in sepsis. Prog Clin Biol Res 1991; 367: 9-24.
3. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-52.
4. Ronald JA, Ionescu CV, Rogers KA, Sandig M. Differential regulation of transendothelial migration of THP-1 cells by ICAM-1/LFA-1 and VCAM-1/VLA-4. J Leukoc Biol 2001; 70: 601-9.
5. Yang, Domingos NCK, M WS. Identification of a Novel Family of Cell-surface Proteins Expressed in Human Vascular Endothelium. The Journal of Biological Chemistry 2002; 277: 46364-73.
6. Madge LA, Pober JS. TNF signaling in vascular endothelial cells. Exp Mol Pathol 2001; 70: 317-25.
7. Colwell J. Pathogenesis of vascular disease. Diabetes Obes Metab 2000; 2 Suppl 2: S19-24.
8. Chen FE, Ghosh G. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene 1999; 18: 6845-52.
9. Senftleben U, Karin M. The IKK/NF-κB pathway. Crit Care Med 2002; 30: S18-S26.
10. Malek S, Chen Y, Huxford T, Ghosh G. IκBbeta, but not IκBα, functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells. The Journal of Biological Chemistry 2001; 276: 45225-35.
11. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002; 109 Suppl: S81-96.
12. Israel A. The IKK complex: an integrator of all signals that activate NF-κB? Trends Cell Biol 2000; 10: 129-33.
13. Wu C, Ohmori Y, Bandyopadhyay S, Sen G, Hamilton T. Interferon-stimulated response element and NF-κB sites cooperate to regulate double-stranded RNAinduced transcription of the IP-10 gene. J Interferon Res 1994; 14: 357-63.
14. Jaffe EA, Nachmen RL, Becker GC, Minick CR. Culture of human endothelial cells from umbilical veins. J Clin Invest 1973; 52: 2745-56.
15. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 1996; 156: 3435-42.
16. Kramer SM, Carver ME. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods 1986; 93: 201-6.
17. Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov S, Johnson PF. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-κB p50. Mol Cell Biol 1998; 18: 5678-89.
18. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gramnegative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. Faseb J 1991; 5: 2652-60.
19. Gupta S, Xia D, Jiang M, Lee S, Pernis AB. Signaling pathways mediated by the TNF- and cytokine-receptor families target a common cis-element of the IFN regulatory factor 1 promoter. J Immunol 1998; 161: 5997-6004.
20. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17: 3261-70.
21. Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161: 984-95.
22. Ayala A, Chaudry IH. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 1996; 6: S27-38.
23. Navarro S, Debili N, Bernaudin JF, Vainchenker W, Doly J. Regulation of the expression of IL-6 in human monocytes. J Immunol 1989; 142: 4339-45.
24. Pucillo CE, Colombatti A, Vitale M, Salzano S, Rossi G, Formisano S. Interactions of promonocytic U937 cells with proteins of the extracellular matrix. Immunology 1993; 80: 248-52.
25. Cannistra SA RA, Spriggs DR, Herrmann F, Kufe D, Griffin JD. Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest 1987; 79: 1720-8.
26. Strefford JC FN, Chaplin T, Neat MJ, Oliver RT, Young BD, Jones LK. The characterisation of the lymphoma cell line U937, using comparative genomic hybridisation and multi-plex FISH. Cytogenet Cell Genet 2001; 94: 9-14.
27. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 2001; 293: 1495-9.
28. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-83.
29. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IκB kinase. Cell 1997; 90: 373-83.
30. Simeonidis S, Stauber D, Chen G, Hendrickson WA, Thanos D. Mechanisms by which IκB proteins control NF-κB activity. Proc Natl Acad Sci USA 1999; 96: 49-54.
31. Spiecker M, Darius H, Liao JK. A functional role of IκB-epsilon in endothelial cell activation. J Immunol 2000; 164: 3316-22.
32. Cheshire JL, Baldwin AS Jr. Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation. Mol Cell Biol 1997; 17: 6746-54.
33. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50.
34. Hinshaw LB. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996; 24: 1072-8.
35. Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D et al. Role of NF-κB in the mortality of sepsis. J Clin Invest 1997; 100: 972-85.
36. Riedemann NC, Ward PA. Anti-inflammatory strategies for the treatment of sepsis. Expert Opin Biol Ther 2003; 3: 339-50.